Spectral Medical Reports Progress on Tigris Clinical Trial
February 11, 2022 08:00 ET
|
Spectral Medical Inc.
Patient mortality data continues to exceed expectations Recent FDA approved SOFA amendment contributing to increased patient enrollment TORONTO, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Spectral Medical...
Spectral Medical Announces U.S. FDA Approval of DIMI Trial Protocol Amendment
January 31, 2022 08:00 ET
|
Spectral Medical Inc.
TORONTO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its wholly-owned subsidiary, Dialco Medical Inc. (“Dialco”) has...
Spectral to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021
December 03, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) and its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced that Chris...
Spectral Medical Schedules Conference Call to Provide Clinical Update and Discuss Latest Developments
November 30, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) and its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced that it will...
Spectral Medical Announces U.S. FDA Approval of Tigris Trial Protocol Amendment to Expand Inclusion Criteria
November 29, 2021 08:00 ET
|
Spectral Medical Inc.
Amendment aligns eligibility for Tigris with current clinical practice in septic shock Potential to improve Tigris enrollment rates by 25% to 50% and reduce time to trial completion Five additional...
Spectral Announces Third Quarter Results and Provides Corporate Update
November 12, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral to Present at the Benzinga Global Small Cap Conference on October 27, 2021
October 25, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) and its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced that Chris...
Spectral and Dialco Announce Dr. John Kellum to Be Featured as Keynote Lecturer at the 39th Vicenza Course on AKI and CRRT
October 20, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) and its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), are pleased to announce that...
Spectral Medical’s CMO Recognized as a World Expert in Sepsis; Supports World Sepsis Day and Sepsis Awareness Month
September 13, 2021 08:00 ET
|
Spectral Medical Inc.
Spectral Sponsors Live Webinar hosted by its CMO at the Sepsis Alliance Symposium September 13th is World Sepsis Day; September is designated as Sepsis Awareness Month TORONTO, Sept. 13,...
Spectral Medical Announces its Participation at Upcoming Investor Conferences
August 23, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing diagnostic and therapeutic options for septic...